--- title: "Solventum Corporation (SOLV.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/SOLV.US.md" symbol: "SOLV.US" name: "Solventum Corporation" industry: "Health Care Supplies" --- # Solventum Corporation (SOLV.US) | Item | Detail | |------|--------| | Industry | Health Care Supplies | | Location | US Market | | Website | [www.solventum.com](https://www.solventum.com) | ## Company Profile Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Meds... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-26T04:30:14.000Z **Overall: C (0.42)** **Industry**: Health Care Supplies | Metric | Value | |--------|-------| | Industry Ranking | 11 / 44 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Large - The company has stable operations, allowing for dependable long-term returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.28% | | | Net Profit YoY | 111.67% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.61 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 13.02B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 8.40B | | **Multi Score**: C #### Profit Score: A | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 37.27% | A | | Profit Margin | 18.14% | A | | Gross Margin | 54.06% | B | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.28% | C | | Net Profit YoY | 111.67% | A | | Total Assets YoY | -5.24% | D | | Net Assets YoY | 56.20% | A | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 551.31% | C | | OCF YoY | 2.28% | C | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.59 | B | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 64.32% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Solventum Corporation", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "A", "indicators": [ { "name": "ROE", "value": "37.27%", "rating": "A" }, { "name": "Profit Margin", "value": "18.14%", "rating": "A" }, { "name": "Gross Margin", "value": "54.06%", "rating": "B" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "2.28%", "rating": "C" }, { "name": "Net Profit YoY", "value": "111.67%", "rating": "A" }, { "name": "Total Assets YoY", "value": "-5.24%", "rating": "D" }, { "name": "Net Assets YoY", "value": "56.20%", "rating": "A" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "551.31%", "rating": "C" }, { "name": "OCF YoY", "value": "2.28%", "rating": "C" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.59", "rating": "B" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "64.32%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Essilor (US.ESLOY) | B | B | C | B | B | B | | 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B | | 03 | Align (US.ALGN) | B | C | B | B | C | B | | 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B | | 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 8.54 | 4/45 | 33.49 | 30.41 | 9.18 | | PB | 2.61 | 24/45 | 3.95 | 3.49 | 2.81 | | PS (TTM) | 1.55 | 14/45 | 1.63 | 1.54 | 1.48 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-24T05:00:00.000Z Total Analysts: **14** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 5 | 36% | | Overweight | 2 | 14% | | Hold | 6 | 43% | | Underweight | 0 | 0% | | Sell | 1 | 7% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 75.08 | | Highest Target | 105.00 | | Lowest Target | 71.00 | ## References - [Company Overview](https://longbridge.com/en/quote/SOLV.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/SOLV.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/SOLV.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.